Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function

Biochemical Pharmacology

Volumn 139, Issue , 2017, Pages 15-23

  Terao, Junji ^a  

^a KONAN WOMEN'S UNIVERSITY   (Japan)

Author keywords

Bioavailability; Flavonoid; Oxidative stress; Quercetin; Vascular function

Indexed keywords

AGLYCONE; ANTIOXIDANT; DRUG METABOLITE; FLAVONOID; HESPERETIN; QUERCETIN; QUERCETIN 3 BETA O GLUCURONIDE; RUTOSIDE; UNCLASSIFIED DRUG;

BIOACCUMULATION; BLOOD FLOW; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CHEMICAL MODIFICATION; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; ENDOTHELIUM CELL; FOOD COMPOSITION; GLYCOSYLATION; HUMAN; INFLAMMATION; INTESTINE ABSORPTION; MACROPHAGE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; ONION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRENYLATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VEGETABLE; ABSORPTION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; BLOOD VESSEL; COMPARATIVE STUDY; DIETARY SUPPLEMENT; DIGESTION; HEALTHY DIET; HYDROLYSIS; IMMUNOLOGY; INTESTINE FLORA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR DISEASES; VASCULAR ENDOTHELIUM;

ABSORPTION, PHYSIOLOGICAL; ANIMALS; ANTIOXIDANTS; BLOOD VESSELS; DIETARY SUPPLEMENTS; DIGESTION; ENDOTHELIUM, VASCULAR; FLAVONOIDS; GASTROINTESTINAL MICROBIOME; GLYCOSYLATION; HEALTHY DIET; HUMANS; HYDROLYSIS; INTESTINAL ABSORPTION; MACROPHAGES; OXIDATIVE STRESS; PRENYLATION; QUERCETIN; VASCULAR DISEASES;

EID: 85017357323     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2017.03.021     Document Type: Review

References (111)

1. Renaud, S., de Lorgeril, M., The French paradox: dietary factors and cigarette smoking-related health risks. Ann. N. Y. Acd. Sci. 686 (1993), 299–309.
2. Constant, J., Alcohol, ischemic heart disease, and the French paradox. Clin. Cardiol. 20 (1997), 420–424.
3. Clozier, A., Jaganath, B., Clifford, M.N., Phenols, polyphenols and tannins: an overview in plant secondary metabolites: occurrence, structure and role in the human diet. Crozier, A., Clifford, M.N., Ashihara, H., (eds.), 2006, Blackwell Publishing, 1–24.
4. Bentsáth, A., Rusznyák, S.T., Szent-Györgyi, A., Vitamin nature of flavones. Nature, 138, 1936, 798.
5. Rezende, B.A., Pereira, A.C., Cortes, S.F., Lemos, V.S., Vascular effects of flavonoids. Curr. Med. Chem. 23 (2016), 87–102.
6. Hertog, M.G., Feskens, E.J., Hollman, P.C., Katan, M.B., Kromhout, D., Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342 (1993), 1007–1011.
7. Williamson, G., Manach, C., Bioavailability and bioefficacy of polyphenols in human II Review of 93 intervention studies. Am. J. Clin. Nutr. 81:Suppl. (2005), 243S–255S.
8. Hooper, L., Kroon, P., Rimm, E.B., Cohn, J.S., Harvey, I., Le Corna, K.A., Ryder, J.J., Hall, W.L., Cassidy, A., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88 (2008), 38–50.
9. Samieri, C., Townsend, M.K., Rimm, E.B., Grodstein, F., Dietary flavonoid intake at midlife and healthy aging in women. Am. J. Clin. Nutr. 100 (2014), 1489–1497.
10. Ivey, K.L., Hodgson, M., Croft, K.D., Lewis, J.R., Prince, R.L., Flavonoid intake and all-case mortality. Am. J. Clin. Nutr. 101 (2015), 1012–1020.
11. Terao, J., Dietary flavonoids as antioxidants. Forum Nutr. 61 (2009), 87–94.
12. Sies, H., Oxidative stress: introductory remarks. Sies, H., (eds.) Oxidative Stress, 1985, Academic Press, London, 1–8.
13. Witztum, J.L., Steinberg, D., Role of oxidized low-density lipoprotein in atherogenesis. J. Clin. Invest. 88 (1991), 1785–1792.
14. Niki, E., Noguchi, N., Effect of antioxidants against atherosclerosis. Mol. Cell. Biochem. 234:235 (2002), 19–25.
15. Kawanishi, S., Oikawa, S., Murata, M., Evaluation for safety of antioxidant chemopreventive agents. Antioxid. Redox Signal. 7 (2005), 1728–1739.
16. Lambert, J.D., Sang, S., Yang, C.S., Possible controversy over dietary polyphenols: benefits vs. risks. Chem. Res. Toxicol. 20 (2007), 583–585.
17. Donovan, J., Manach, C., Faulks, R.M., Kroon, P.A., Absorption and metabolism of dietary plant secondary metabolites in plant secondary metabolites: occurrence, structure and role in the human diet. Crozier, A., Clifford, M.N., Ashihara, H., (eds.), 2006, Blackwell Publishing, 303–351.
18. Hollman, P.C., Cassidy, A., Comte, B., Heinonen, M., Richelle, M., Richling, E., Serafini, M., Scalbert, A., Sies, H., Vidry, S., The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J. Nutr. 141 (2011), 989s–1009s.
19. Lotito, S.B., Frei, B., Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon. Free Radical Biol. Med. 41 (2006), 1727–1746.
20. Shanely, R.A., Knab, A.M., Nieman, D.C., Jin, F., McAnulty, S.R., Landram, M.J., Quercetin supplementation does not alter antioxidant status in humans. Free Radical Res. 44 (2010), 224–231.
21. Tachibana, H., Koga, K., Fujimura, Y., Yamada, K., A receptor for green tea polyphenol EGCG. Nat. Struct. Mol. Biol. 11 (2004), 380–381.
22. Murakami, A., Ohnishi, K., Target molecules of food phytochemicals: food science bound for the next dimension. Food Funct. 3 (2012), 462–476.
23. Marinho, H.S., Real, C., Cyrne, L., Soares, H., Antunes, F., Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol. 2 (2014), 535–562.
24. Sies, H., Jones, D., Oxidative stress. Fink, G., (eds.) Encyclopedia of Stress 3, 2nd ed, 2007, Elsevier, Amsterdam, 45–48.
25. Terao, J., Integrated studies on the action mechanism of oxidative stress-regulating food bioactives. J. Jpn. Sci. Nutr. Food Sci. 68 (2015), 3–11.
26. Toh, J.Y., Tan, V.M.H., Lim, P.C.Y., Lim, S.T., Chong, M.F.F., Flavonoids from fruit and vegetables: a focus on cardiovascular risk factors. Curr. Athroscler. Rep., 15, 2013, 368.
27. Del Rio, A.D., Rodoriguez-Mateos, A., Spencer, J.P.E., Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effect against chronic diseases. Antiox. Redox Signal. 18 (2013), 1818–1892.
28. Feliciano, R.P., Pritzel, S., Hess, C., Rodriguez-Mateos, A., Flavonoid intake and cardiovascular disease risk. Curr. Opinion Food Sci. 2 (2015), 92–99.
29. Cassidy, A., Minihane, A.-M., The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Am. J. Clin. Nutr. 105 (2017), 10–22.
30. Schaffer, S., Halliwell, B., Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations. Genes Nutr. 7 (2012), 99–109.
31. Terao, J., Kawai, Y., Murota, K., Vegetable flavonoids and cardiovascular disease Asia Pac. J. Clin. Nutr. 17S (2008), 291–293.
32. Terao, J., Flavonols; metabolism, bioavailability and health impacts. Fraga, C.G., (eds.) Plant Phenolics and Human Health, 2009, Wiley and Sons Inc., Hoboken, 185–196.
33. Loke, W.M., Proudfood, J.M., Hodgson, J.M., Mckinley, A.J., Hime, N., Magat, M., Stocker, R., Croft, K.D., Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Artheroscler. Throm. Vasc. Biol. 30 (2010), 749–757.
34. Hollman, P.C., Geelen, A., Kromhout, D., Dietary flavonol intake may lower stroke risk in men and women. J. Nutr. 140 (2010), 600–604.
35. Edwards, R.L., Lyon, T., Litwin, S.E., Rabovsky, A., Symons, J.D., Jalili, T., Quercetin reduces blood pressure in hypertensive subjects. J. Nutr. 137 (2007), 2405–2411.
36. Loke, W.L., Hodgson, M., Proudfoot, J.M., Mckinley, A.J., Puddey, I.B., Croft, K.D., Pure dietary flavonoids quercetin and (−)-epicatehin augment nitric oxide products and reduce endothlin-1 acutely in healthy men. Am. J. Clin. Nutr. 88 (2008), 1018–1025.
37. Egert, S., Bosy-Westphal, A., Seiberl, J., Kurbitz, C., Settler, U., Plachta-Danielzik, S., Wggner, A.E., Frank, J., Schrezenmeir, J., Rimbach, G., Wolffram, S., Müller, M.J., Quercetin reduces systolic blood pressure and plasma oxidized low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Brit. J. Nutr. 102 (2009), 1065–1074.
38. Lee, K.H., Park, E., Lee, H.J., Kim, M.O., Cha, Y.J., Kim, J.M., Lee, H., Shin, M.J., Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokers. Nutr. Res. Pract. 5 (2011), 28–33.
39. Zahedi, M., Ghiasvand, R., Feizi, A., Asqari, G., Darvish, L., Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-bind randomized controlled clinical trial. Int. J. Prev. Med. 4 (2013), 777–785.
40. Pfeuffer, M., Auinger, A., Bley, U., Kraus-stojanowic, J., Laue, C., Winkler, P., Rufer, C.E., Frank, J., Bosch-Saadatmandi, C., Rimbach, G., Schrezenmeir, J., Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms. Nutr. Metab. Cardiovas. Dis. 23 (2013), 403–409.
41. Perez, A., Gonzalez-Manzano, S., Jimenez, R., Perez-Abud, R., Haro, J.M., Osuna, A., Santos-Buelga, C., Duarte, J., Perez-Vizcaino, F., The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: correlation with beta-glucuronidase activity. Pharmacol. Res. 89 (2014), 11–18.
42. Dower, J.I., Geleijnse, J.M., Gijsbers, L., Schalkwijk, C., Kromhour, D., Hollman, P.C., Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre)hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial. J. Nutr. 145 (2015), 1459–1463.
43. Dower, J.I., Geleijnse, J.M., Gijsbers, L., Zock, P.L., Kromhour, D., Hollman, P.C., Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 101 (2015), 914–921.
44. Nishimuro, H., Ohnishi, H., Sato, M., Ohnishi-Kameyama, M., Matshunaga, I., Naito, S., Ippoushi, K., Oike, H., Nagata, T., Akasaka, H., Saitoh, S., Shimamoto, K., Kobori, M., Estimated daily intake and seasonal food sources of quercetin in Japan. Nutrients 7 (2015), 2345–2358.
45. Griffiths, G., Trueman, L., Crowther, T., Thomas, B., Smith, B., Onions-a global benefit to health. Phytother. Res. 16 (2002), 603–615.
46. Tsushida, T., Suzuki, M., Contents of flavonol glucosides and some properties of enzymes: metabolizing the glucosides in onion. Nippon Shokuhin Kagaku Kaisih 43 (1996), 642–649.
47. Janssen, P.L.T.M., Mensink, R.P., Cox, F.J.J., Harryvan, J.L., Hovenier, R., Hollman, P.C.H., Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and dietary supplement study. Am. J. Clin. Nutr. 67 (1998), 255–262.
48. Lean, M.E.J., Noroozi, M., Kelly, I., Burns, J., Talwar, D., Sattar, N., Crozier, A., Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes 48 (1999), 176–181.
49. Boyle, S.P., Dobson, V.L., Duthie, S.J., Kyle, J.A.M., Collins, A.R., Absorption and DNA protective effects of flavonoid glycosides from an onion meal. Eur. J. Nutr. 39 (2000), 213–223.
50. Nakayama, H., Tsuge, N., Sawada, H., Higashi, Y., Chronic intake of onion extract containing quercetin improved postprandial endothelial dysfunction in healthy men. J. Am. Coll. Nutr. 32 (2013), 160–164.
51. Ebrahimi-Mamaghani, M., Saghafi-Asl, M., Pirouzpanah, S., Asghari-Jafarabadi, M., Effects of raw red onion consumption on metabolic features in overweight or obese women with polycystic ovary syndrome: a randomized controlled clinical trial. J. Obestet. Gynaecol. Res. 40 (2014), 1067–1076.
52. Brüll, V., Burak, C., Stoffel-Wagner, B., Wolffram, S., Nickenig, G., Müller, C., Langguth, P., Alteheld, B., Fimmers, R., Naaf, S., Zimmermann, B.F., Stehle, P., Egert, S., Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blind placebo-controlled cross-over trial. Br. J. Nutr. 114 (2015), 1263–1277.
53. Clifford, M.N., Justin, J.J., Van der Hooft, Crozier, A., Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols. Am. J. Clin. Nutr. 98 (2013), 1619S–1630S.
54. Murota, K., Terao, J., Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys. 417 (2003), 12–17.
55. Piskula, M.K., Murota, K., Terao, J., Bioavailability of flavonols and flavones. Spencer, J.P.E., Clozier, A., (eds.) Flavonoids and Related Compounds-Bioavailability and Function, 2012, CRC Press, Boca Raton, 93–108.
56. Moon, J.H., Nakata, R., Oshima, S., Inakuma, T., Terao, J., Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. Am. J. Physiol. 279 (2000), R461–R467.
57. Egert, S., Wolffram, S., Bosy-Wesphal, A., Boesch-Saadatmandi, C., Wagner, A.E., Frank, J., Rimbach, G., Mueller, M.J., Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J. Nur. 138 (2008), 1615–1621.
58. Jin, F., Nieman, D.C., Shanely, R.A., Knab, A.M., Austin, M.D., Sha, W., The variable plasma quercetin response to 12-week quercetin supplementation in humans. Eur. J. Clin. Nutr. 64 (2010), 692–697.
59. Cialdella-Kam, L., Nieman, D.C., Sha, W., Meaney, M.P., Knab, A.M., Shanely, R.A., Dose-response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults. Br. J. Nutr. 109 (2013), 1923–1933.
60. Rotherll, J.A., Day, A.J., Morgan, M.R.A., Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids. J. Agric. Food Chem. 53 (2005), 4355–4360.
61. Piskula, M., Terao, J., Quercetin's solubility affects its accumulation in rat plasma after oral administration. J. Agric. Food Chem. 46 (1998), 4313–4317.
62. Erlund, I., Kosonen, G., Alfthan, J., Maenpaa, K., Pertunen, J., Kenraali, A.A., Parantainen. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol. 56 (2000), 545–553.
63. Murota, K., Matsuda, N., Kashino, Y., Fujikura, Y., Nakamura, T., Kato, Y., Shimizu, R., Okuyama, S., Tanaka, H., Koda, T., Sekido, K., Terao, J., A-Oligoglucosylation of a sugar moiety enhances the bioavailability of quercetin glucosides in humans. Arch. Biochem. Biophys. 501 (2010), 91–97.
64. Katneni, K., Charman, S.A., Porter, C.J., Evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in vitro intestinal permeability of drug compounds of varying lipophilicity. J. Pharm. Pharmacol. 60 (2008), 1311–1319.
65. Yazaki, K., Sasaki, K., Tsurumaru, Y., Prenylation of aromatic compounds, a key diversification of plant secondary metabolites. Phytochemistry 70 (2009), 1739–1745.
66. Chen, X., Mukwaya, E., Wong, M.S., Zhang, Y., A systematic review on biological activities of prenylated flavonoids. Pharm. Biol. 52 (2014), 655–660.
67. Hisanaga, A., Mukai, R., Sakao, K., Terao, J., Hou, D.X., Anti-inflammatory effects and molecular mechanisms of 8-prenyl quercetin. Mol. Nutr. Food Res. 60 (2016), 1020–1032.
68. Mukai, R., Fujikura, Y., Murota, K., Uehara, M., Minekawa, S., Matsui, N., Kawamura, T., Nemoto, H., Terao, J., Prenylation enhances quercetin uptake and reduces efflux in Caco-2 cells and enhances tissue accumulation in mice fed long-term. J. Nutr. 143 (2013), 1558–1564.
69. Terao, J., Mukai, R., Prenylation modulates the bioavailability and bioaccumulation of dietary flavonoids. Arch. Biophem. Biophys. 559 (2014), 12–16.
70. Bohn, T., Dietary factors affecting polyphenol bioavailability. Nutr. Rev. 72 (2014), 429–452.
71. Guo, Y., Bruno, R., Endogeneous and exogeneous mediators of quercetin bioavailability. J. Nutr. Biochem. 26 (2015), 1201–1210.
72. Guo, Y., Mah, E., Davis, C.G., Jalili, T., Ferruzzi, M.G., Churi, O.K., Bruno, R.S., Dietary fat increases quercetin bioavailability in overweight adults. Mol. Nutr. Food Res. 57 (2013), 896–905.
73. Wiczkowski, W., Romaszko, J., Bucinski, A., Szawara-Nowak, D., Honke, J., Zielinski, H., Piskula, M.K., Querctin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides. J. Nutr. 138 (2008), 885–888.
74. Shi, Y., Williamson, G., Comparison of the urinary excretion of quercetin glycosides from dietary supplements in healthy subjects: a randomized, single-blind, cross-over study. Food Funct. 6 (2015), 1443–1448.
75. Burak, C., Brüll, V., Langguth, P., Zimmermann, B.F., Stoffel-Wagner, B., Sausen, U., Stehle, P., Wolffram, S., Egert, S., Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dehydrate in humans. Eur. J. Nutr. 56 (2017), 343–353.
76. Egert, S., Wolffram, S., Schultze, B., Langguth, P., Hubbermann, E.M., Schwarz, K., Adolphi, B., Bosy-Westphal, A., Rimbach, G., Muller, M.J., Enriched cereal bars are more effective in increasing plasma quercetin compared with quercetin from powder-filled hard capsules. Brit. J. Nutr. 107 (2012), 539–546.
77. Rerez-Vizcaino, F., Duarte, J., Andriantsitohaina, R., Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radical Res. 40 (2006), 1054–1065.
78. Perez-Vizcaino, F., Duarte, J., Flavonols and cardiovascular disease. Mol. Aspects Med. 31 (2010), 478–494.
79. Bondonno, N.P., Bondonno, C.P., Hodgson, J.M., Ward, N.C., Croft, K.D., The efficacy of quercetin in cardiovascular health. Curr. Nutr. Rep. 4 (2015), 290–303.
80. Kawai, Y., Nishikawa, T., Shiba, Y., Saito, S., Murota, K., Shibata, N., Kobayashi, M., Kanayama, M., Uchida, K., Terao, J., Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J. Biol. Chem. 283 (2008), 9424–9434.
81. Murota, K., Hotta, A., Ido, H., Kawai, Y., Moon, J.H., Sekido, K., Hayashi, H., Inakuma, T., Terao, J., Antioxidant capacity of albumin-bound quercetin metabolites after onion consumption in humans. J. Med. Invest. 54 (2007), 370–374.
82. Lodi, F., Jiménez, R., Menendez, C., Needs, P.W., Duarte, J., Perez-Vizcaino, F., Glucuronidated metabolites of the flavonoid quercetin do not auto-oxidise, do not generate free radicals and do not decrease nitric oxide bioavailability. Planta Med. 74 (2008), 741–746.
83. Boesch-Saadatmandi, C., Loboda, A., Wagner, A.E., Stachurska, A., Jozkowicz, A., Duarte, J., Doring, F., Wolffram, S., Rimbach, G., Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J. Nutr. Biochem. 22 (2011), 293–299.
84. Ishisaka, A., Kawabata, K., Miki, S., Shiba, Y., Minekawa, S., Nishikawa, T., Mukai, R., Terao, J., Kawai, Y., Mitochondrial dysfunction leads to deconjugation of quercetin glucuronides in inflammatory macrophages. PLoS One, 8, 2013, e80843.
85. Shimoi, K., Saka, N., Nozawa, R., Sato, M., Amano, I., Nakayama, T., Kinae, N., Deconjugation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metab. Dispos. 29 (2001), 1521–1524.
86. Lee-Hilz, Y., Stolaki, M., van Berkel, W.J.H., Aats, J.M.M.J.G., Ritjens, I.M.C.M., Activation of EpRE-mediated gene transcription by quercetin glucuronides depends on their deconjugation. Food Chem. Toxicol. 46 (2008), 2128–2134.
87. Bartholome, R.B., Haenen, G., Hollman, P.C., Bast, A., Dagnelie, P.C., Roos, D., Keuer, J., Kroon, P.A., Needs, P.W., Arts, I.C.W., Deconjugation kinetics of glucuronidated phase II flavonoid metabolism by β-glucuronides from neutrophils. Drug Metab. Pharmacokinet. 25 (2010), 379–387.
88. Menendez, C., Duenas, M., Galindo, P., Gonzalez-Manzano, S., Jimenez, R., MorenoL, L., Zarzulo, M.J., Rodriguez-Gomez, I., Duarte, J., Santo-Buelga, C., Perez-Vizcaino, F., Vascular deconjugation of quercetin glucuronide: the flavonoid paradox revealed?. Mol. Nutr. Food Res. 55 (2011), 1780–1790.
89. Galindo, P., Rodoriguez-Gómez, González-Manzano, S., Dueñas, M., Jiménez, R., Menendez, C., Vargas, F., Tamargo, J., Santos-Buelga, C., Pérez-Vizcaino, F., Duarte, J., Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation. PLoS ONE, 7, 2012, e32673.
90. Perez, A., Gonzalez-Manzano, S., Jimenez, R., Perez-Abud, R., Haro, J.M., Osuna, A., Santos-Buelga, C., Duarte, J., Pérez-Vizcaino, F., The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: correlation with beta-glucuronidase activity. Pharmacol. Res. 89 (2014), 11–18.
91. Wiczkowski, W., Skipo, J., Misztal, T., Szawara-Nowak, D., Topoiska, J., Piskula, M.K., Quercetin and isorhamnetin aglycones are the main metabolites of dietary quercetin in cerebrospinal fluid. Mol. Nutr. Food Res. 59 (2015), 1088–1094.
92. Ishisaka, A., Mukai, R., Terao, J., Shibata, N., Kawai, Y., Specific localization of quercetin-3-O-glucuronide in human brain. Arch. Biochem. Biophys. 557 (2014), 11–17.
93. Terao, J., Murota, K., Kawai, Y., Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglycone in vivo. Food Func. 2 (2011), 11–17.
94. de Pascual-Teresa, S., Johnston, K.L., DuPont, M.S., O'Leary, K.A., Needs, P.W., Morgan, L.M., Clifford, M.N., Bao, Y., Williamson, G., Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo. J. Nutr. 134 (2004), 552–557.
95. Lodi, F., Winterbone, M.S., Tribolo, S., Need, P.W., Hughes, D.A., Kroon, P.A., Human quercetin conjugated metabolites attenuate TNF-α-induced changes in vasomodulatory molecules in an HUASMCs/HUVECs co-culture model. Planta Med. 78 (2012), 1571–1753.
96. Lodi, F., Jimenez, R., Moreno, L., Kroon, P.A., Needs, P.W., Hughes, D.A., Santos-Buelga, C., Gonzalez-Paramas, A., Cogolludo, A., Lopez-Sepulveda, R., Duarte, J., Perez-Vizcaino, F., Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis 204 (2009), 34–39.
97. Tribolo, S., Lodi, F., Connor, C., Suri, S., Wilson, V.G., Taylor, M.A., Needs, P.W., Kroon, P.A., Hughes, D.A., Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 197 (2008), 50–56.
98. Hirase, T., Node, K., Endothelial dysfunction as a cellular mechanism for vascular failure. Am. J. Physiol. Heart Circ. Physiol. 302 (2012), H499–H505.
99. Frostegård, J., Haegerstrand, A., Gidlund, M., Nilsson, J., Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis 90 (1991), 119–126.
100. Kamada, C., Mukai, R., Kondo, A., Sato, S., Terao, J., Effect of quercetin and its metabolite on caveolin-1 expression induced by oxidized LDL and lysophosphatidylcholine in endothelial cells. J. Clin. Biochem. Nutr. 58 (2016), 193–201.
101. Rahman, A., Sward, K., The role of caveolin-1 in cardiovascular regulation. Acta Physiol. 195 (2009), 231–245.
102. Pavilides, P.S., Gutierrez-Pajares, J.L., Iturrieta, J., Lisanti, M.P., Endothelial caveolin-1 plays a major role in the development of atherosclerosis. Cell Tissue Res. 356 (2014), 147–157.
103. Fermandez-Hermnando, C.Z., Yu, J., Suarez, Y., Rahner, C., Davaios, A., Lasuncion, M.A., Sessa, W.C., Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. Cell Metab. 10 (2009), 48–54.
104. Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., Russo, G.L., The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol. 83 (2012), 6–15.
105. Biasutto, L., Sassi, N., Mattarei, A., Marotta, E., Cattelan, P., Toninello, A., Garbisa, S., Zoratti, M., Paradisi, C., Impact of mitochondriotropic quercetin derivatives on mitochondria. Biochem. Biophys. Acta 1797 (2010), 189–196.
106. van Duynhoven, J., Vaughan, E.E., Jacobs, D.M., Kemperman, R.A., van Velzen, E.J.J., Gross, G., Roger, L.C., Possemiers, S., Smilde, A.K., Doré, J., Westerhuis, J.A., Van de Wiele, T., Metabolic fate of polyphenols in the human superorganism. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 4531–4538.
107. Roopchand, D.E., Carmody, R.N., Kuhn, P., Moskal, K., Rojas-Silva, P., Turnbaugh, P.J., Raskin, I., Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. Diabetes 64 (2015), 2847–2858.
108. Anhê, F.F., Pilon, G., Roy, D., Desjardins, Y., Levy, E., Marette, A., Triggering Akkermansia with dietary polyphenols: a new weapon to combat the metabolic syndrome ?. Gut Microbes 7 (2016), 146–153.
109. Kawabata, K., Sugiyama, Y., Sakano, T., Ohigashi, H., Flavonols enhanced production of anti-inflammatory substance(s) by Bifidobacterium adolescentis: prebiotic actions of galangin, quercetin, and fisetin. BioFactors 39 (2013), 422–429.
110. Heart protection study collaborative group, MRC/BHF heart protection study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360 (2002), 23–33.
111. Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G., Gluud, C., Mortality in randomized trials of antioxidant supplements for primary and secondary prevention-Systematic review and meta-analysis. JAMA 297 (2007), 842–857.